RNAI rally underway, page-2

And Vertex announcing they want to buy into RNAi and gene therapy as well..the following from Fiercebio o/night.

Vertex ($VRTX) is ready to get its checkbook out to quell talk of it being a takeover target for Biogen ($BIIB) and Gilead ($GILD). The plan is to use the cash flow from recently approved cystic fibrosis drug Orkambi to strike pipeline-broadening deals, with gene therapy and RNA two fields in the company's sights.